Benevira is a privately owned synthetic biology company developing and manufacturing antiviral biologics, therapeutics, and consumer health products. Its technology targets viral evolutionary bottlenecks to create sustainable treatments and prophylactics for emerging and established viral diseases, including COVID-19 and influenza.
Intervir LLCIntervir LLC is a pharmaceutical manufacturing company focused on discovering novel antiviral therapeutics.PHILADELPHIA, PA
Evrys BioFounded by Princeton scientists and drug-development leaders, Doylestown-based Evrys Bio develops antiviral therapies that target host-cell SIRT2 rather than the virus itself. Its small-molecule approach is designed to work across a broad spectrum of viral infections while limiting the development of drug resistance, with EV-100 identified as its clinic-ready lead asset.DOYLESTOWN, PA
TechnoVax IncFounded in 2004, privately held TechnoVax is a New York metro-area biotechnology company developing viral vaccines through a cell-based virus-like particle platform. Its near-clinical-stage work centers on vaccine candidates for influenza and RSV, including an inhaled powder approach developed with a pulmonary drug-delivery partner. The company also provides biological products and collaborative research services for vaccine, diagnostic, and research applications.ELMSFORD, NY
Medigen, IncMedigen, Inc. is a biomedical and vaccine company developing vaccines for emerging infectious diseases, chronic diseases including cancer, and other biopharmaceutical applications. Its explicitly described capabilities include vaccine manufacturing, cGMP production of cell and virus banks, virus and protein drug substance production, fill-finish, VLP design and production, molecular biology, electron microscopy, protein expression, and protein purification.FREDERICK, MD